Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury

[1]  S. Yadav.  Gastrointestinal Toxicity of Nonsteroidal Anti-inflammatory Drugs in Maxillofacial Trauma Patients: A Review , 2012 .

[2]  E. Ongini,et al.  Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. , 2011, Gastroenterology.

[3]  F. Chan,et al.  Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial , 2010, The Lancet.

[4]  C. Sakamoto,et al.  Distribution of small intestinal mucosal injuries as a result of NSAID administration , 2010, European journal of clinical investigation.

[5]  D. McCarthy.  GI bleeding: problems that persist. , 2009, Gastrointestinal endoscopy.

[6]  J. Wallace.  Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? , 2008, Physiological reviews.

[7]  A. Seigal,et al.  Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  R. Sidhu,et al.  Capsule endoscopy for the evaluation of nonsteroidal anti-inflammatory drug-induced enteropathy: United Kingdom pilot data. , 2006, Gastrointestinal endoscopy.

[9]  W. Simon,et al.  Hydroxyl radical scavenging reactivity of proton pump inhibitors. , 2006, Biochemical pharmacology.

[10]  Á. Lanas,et al.  Microbial Flora in NSAID-Induced Intestinal Damage: A Role for Antibiotics? , 2006, Digestion.

[11]  黒田 雅昭.  Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis , 2006 .

[12]  G. Thiéfin,et al.  Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. , 2005, Joint, bone, spine : revue du rhumatisme.

[13]  B. Thjódleifsson,et al.  A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. , 2005, Gastroenterology.

[14]  B. Lewis,et al.  Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  D. Graham,et al.  Visible small-intestinal mucosal injury in chronic NSAID users. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  L. Laine,et al.  Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysis. , 2004, The American journal of medicine.

[17]  K. Chu,et al.  Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti‐inflammatory drug users – a randomized trial , 2003, Alimentary pharmacology & therapeutics.

[18]  A. Toor,et al.  Lansoprazole-associated microscopic colitis: a case series , 2002, American Journal of Gastroenterology.

[19]  V. Nousias,et al.  A comparative experimental study of the effects of diclofenac and ketoprofen on the small-bowel mucosa of canines , 2001, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[20]  J. Bolognese,et al.  COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin , 2000, Gut.

[21]  M. Wolfe,et al.  Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. , 1999, The New England journal of medicine.

[22]  E. O'Loughlin,et al.  The effect of epidermal growth factor on brush border surface area and function in the distal remnant following resection in the rabbit , 1999, Gut.

[23]  A. Barkun,et al.  Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. , 1999, The New England journal of medicine.

[24]  A. Buret,et al.  Effects of Orally Administered Epidermal Growth Factor on Enteropathogenic Escherichia coli Infection in Rabbits , 1998, Infection and Immunity.

[25]  H D Langtry,et al.  Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs. , 1998, Drugs.

[26]  A. Barkun,et al.  Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs , 1998 .

[27]  D. Easty,et al.  Immunohistochemical detection of cytokines in paraffin-embedded mouse tissues. , 1997, Journal of immunological methods.

[28]  N. Davies,et al.  Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. , 1997, Gastroenterology.

[29]  R. Sedivy,et al.  Epidermal growth factor promotes rapid response to epithelial injury in rabbit duodenum in vitro. , 1996, Gastroenterology.

[30]  R. Playford,et al.  Why is epidermal growth factor present in the gut lumen? , 1996, Gut.

[31]  A. Macpherson,et al.  Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. , 1993, Gastroenterology.

[32]  C. Torrance,et al.  Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. , 1992, The New England journal of medicine.

[33]  J. Wallace,et al.  Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. , 1992, Gastroenterology.

[34]  A. Levi,et al.  Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. , 1987, Gastroenterology.

[35]  D. Kennedy,et al.  Utilization of nonsteroidal antiinflammatory drugs. , 1985, Arthritis and rheumatism.

[36]  O'brien Wm,et al.  Rare adverse reactions to non-steroidal anti-inflammatory drugs , 1985 .

[37]  H. Scott,et al.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.